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Mass analysis of recombinant protein therapeutics is an important assay for product charac-
terization. Intact mass analysis is used to provide confirmation of proper translation of the
DNA sequence and to detect the presence of post-translational modifications such as amino
acid processing and glycosylation. We present here a method for the rapid mass analysis
of antibodies using a polyhydroxyethyl aspartamide column operated in size-exclusion mode
and coupled with ESI-MS. This method allows extremely efficient desalting of proteins under
acidic conditions that are optimal for subsequent mass analysis using standard ESI conditions.
Furthermore, this technique is significantly faster and more sensitive than rpHPLC methods,
typically considered the standard chromatography approach for mass analysis of proteins.
This method is flexible and robust, and should prove useful for applications where a
combination of speed and sensitivity are required. (J Am Soc Mass Spectrom 2008, 19,
502–509) © 2008 American Society for Mass SpectrometryMass analysis of recombinant proteins is a keycharacterization assay used to evaluate theentire amino acid sequence of the molecule
and the presence of post-translational modifications. As
part of protein drug development, intact mass analysis
supports the characterization package for regulatory
filings and may be used to evaluate lot-to-lot consis-
tency on a whole molecule level. Mass analysis of intact
or reduced antibodies has been used to evaluate the
degree of processing of C-terminal lysine on the heavy
chain subunit [1]; evaluate N-terminal heterogeneity
such as pyroglutamic acid formation [2, 3]; profile
N-linked carbohydrate heterogeneity [3, 4]; and to de-
tect instabilities in the molecule such as oxidation [5],
succinimide formation from aspartic acid [6], glycation
[7], internal cleavage [8], and thioether formation [9].
Reversed-phase HPLC (rpHPLC) separation followed
by electrospray ionization-mass spectrometry (ESI-MS)
analysis is the typical method for analyzing antibodies
under both non-reduced and reducing conditions. This
method is highly resolving and advantageous for the
detection of minor product impurities and the resolu-
tion of different amino acid sequences or heterogeneous
post-translational modifications. However, rpHPLC of
antibodies has several distinct disadvantages. Due to
the large size and relatively hydrophobic nature of
antibodies, high temperatures are typically employed to
improve elution and peak shape profiles [1, 4]. How-
ever, high temperatures may lead to artifactual degra-
dation of the sample during analysis. Inclusion of TFA
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to obtain good chromatography [1], but may result in
decreased ionization [10, 11]. Additionally, reduction of
antibodies and analysis of the constituent light and
heavy chains often results in tailing of the heavy-chain
component and the potential for carry-over problems.
These issues can lead to lengthened run times or the
inclusion of blank runs between samples to increase
confidence in the results.
We optimized the use of a commercially available
polyhydroxyethyl aspartamide column operated in SEC
mode (pHEA-SEC) for the rapid on-line analysis of
antibodies. This chromatographic material has been
originally developed for the separation of polar com-
pounds by hydrophilic interaction chromatography
[12]. By operating this column in 0.1% formic acid
under isocratic conditions and introducing organic sol-
vent by post-column addition, we developed a robust
and fast separation method that is highly flexible and
tolerates numerous sample buffer components. Addi-
tionally, this new approach differs from other reported
SEC-MS methods, achieving a rapid separation in the
absence of salts [13] or organic modifiers [14]. We were
able to interface this method with an ESI-TOF mass
spectrometer and obtained very high quality mass data
with experimental to theoretical mass agreements be-
low 25 ppm for several intact antibodies. Furthermore,
since this method is highly tolerant of different sample
buffer components, we were able to use the same
method, without modification, for the analysis of re-
duced antibody samples. This method is a highly flex-
ible and broadly applicable chromatography procedure
for mass analysis of proteins.
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Molecules
The CHO-expressed monoclonal antibodies (MAb) used
in this study were manufactured at Amgen, Bothell, WA.
Column Conditioning and Operation
A 2.1  250 mm polyhydroxyethyl aspartamide
(pHEA) 300 Å column received from the manufacturer
(PolyLC, Inc., Columbia, MD) was conditioned by op-
erating for 12 to 18 h at 0.2 mL/min on 0.1% formic acid
(vol/vol). After this initial conditioning step, the col-
umn was operated in the same solvent at 0.1 mL/min at
ambient temperature. The column was stored in the
same solvent and samples analyzed after operating the
column for 10 to 30 min at 0.1 mL/min. For each
sample, the column was operated for 8 min as described
in the Results and Discussion section.
Post-Column Addition of Organic Solvent
Acetonitrile with 2.0% (vol/vol) formic acid was
added post-column using a stainless steel tee at
0.1 mL/min using an LC Packings “Switchos” mod-
ule (Dionex, Inc., Sunnyvale, CA). Any pump capable
of providing stable flows of 0.1 mL/min at backpres-
sures up to 20 to 30 bar (due to constriction at the
inlet of the mass spectrometer) is appropriate.
Sample Preparation and Column Injection Levels
Non-reduced samples were analyzed following dilution
to 2 mg/mL with water. For reduced samples, the
protein was diluted to 2 mg/mL with 20 mMDTT in 6.0
M guanidine HCl/100 mM Tris, pH 8.0 and incubated
for 30 min at 37 °C. For all samples, an injection of 2 L
(corresponding to 4 g) was made onto the column
except as noted in the text.
Mass Spectrometry
The outlet of the mixing tee used to add organic solvent
post-column was connected to the internal divert valve
attached to an Agilent TOF (model 6210) mass spec-
trometer (Agilent, Inc., Santa Clara, CA). Key source
parameters were as follows: nitrogen gas flow of 9 L/min;
fragmenter voltage of 415 V for non-reduced samples
and 250 V for reduced samples; capillary voltage of
5000 V for non-reduced samples and 4000 V for reduced
samples; and nebulizer pressure of 60 psi. Other condi-
tions were standard ones used with positive ESI for the
Agilent TOF. The TOF was calibrated over the range
0–4000 m/z using Agilent ESI calibration mix before
analysis with an overall mass error for all points below
3 ppm.Reversed-Phase HPLC
Separation by rpHPLC was performed similar to the
method described in [1]. Briefly, a 2.1  150 mm, 300 Å
Zorbax SB-C8 column (Agilent) was operated at 0.3
mL/min at 75 °C. Solvent A was water  0.12% triflu-
oroacetic acid (TFA) (wt/vol) and Solvent B was 10:
80:10 water:2-propanol:acetonitrile  0.10% TFA (wt/
vol). Samples were loaded (levels described in the text)
in 10% B and eluted with a gradient to 90% B in 20 min.
Deconvolution
Deconvolution was performed in two ways. For non-
reduced samples, spectra corresponding to chromato-
graphic peaks were exported to text files, imported into
MassLynx (Waters, Inc., Milford, MA) and deconvoluted
using the MaxEnt1 algorithm. For MaxEnt1 deconvolu-
tion, an appropriate peak width value was selected and
the data iterated to convergence with an output resolution
of 1.0 Da/channel; other parameters were default values
for the software. For reduced samples, the deconvolution
program supplied by Agilent (within MassHunter Work-
station) was used in “automatic” mode.
Results and Discussion
Several features of the size-based separation achieved
using pHEA-SEC chromatography make it ideal as a
general method for analysis of proteins by mass spec-
trometry. The first advantage offered by this column is
the similar elution profiles obtained for proteins of
different sizes and shapes, allowing it to be used as a
general method without sample specific development.
In pHEA-SEC, proteins are separated from salts and
other buffer components under isocratic flow condi-
tions in aqueous solvent acidified with 0.1% (vol/vol)
formic acid. By adding acetonitrile post-column, pro-
teins are introduced to the source under conditions
ideal for subsequent ESI analysis. This second feature of
pHEA-SEC presents an advantage over typical rpHPLC
methods, which usually employ TFA as an organic
modifier. The negative impact of TFA on ionization of
proteins in ESI is well known [10, 11]. However, TFA is
often employed as an additive to rpHPLC-based sepa-
rations before MS analysis because of the advantages
this modifier gives to elution peak shapes [1]. Although
other modifiers, such as formic acid or acetic acid, may
give better ionization, the chromatographic profiles
obtained for proteins are often unacceptable when these
counter-ions are employed. In contrast, one significant
advantage of pHEA-SEC is the ability to separate pro-
tein samples in formic acid while maintaining excellent
chromatographic peak shape. To demonstrate the ad-
vantages this method offers over rpHPLC based ap-
proaches, we compared chromatography and ESI-MS
results obtained for an antibody sample analyzed by
pHEA-SEC compared with the same sample separated
using an optimized TFA-based rpHPLC method. Figure
504 BRADY ET AL. J Am Soc Mass Spectrom 2008, 19, 502–5091 shows a comparison of the A214 nm and total ion
current (TIC) traces obtained for the sample at two
different sample loads: 4 g and 20 g. Comparison of
the UV traces for the two methods showed similar UV
peak area values once differences in flow rate between
the two methods were accounted for. Although we
routinely analyze 4 g of protein using pHEA-SEC with
good results, this level of injection was too low to obtain
good data by rpHPLC. To compare TIC traces between
the two methods, injection amounts typical of the two
approaches were compared (20 g for rpHPLC and
4 g for pHEA-SEC). Even though 5-fold greater pro-
tein was injected on the rpHPLC column, the intensity
obtained by pHEA-SEC was still 45-fold higher.
Inspection of the A214 nm traces shown in Figure 1
for the pHEA-SEC separation shows several aspects of
the method. The intact antibody eluted at about 3.5 min,
or 350 L. Since the concentrations of salts in this
sample are low in proportion to the protein, no salt
peak is present. However, in the 20 g injection, where
a greater volume was injected on the column, a negative
absorbance peak can be seen at about 7.5 min (or 750
L). This peak is due to the separation of water in the
sample from the antibody; the negative peak is caused
Figure 1. Comparison of the A214 nm traces
rpHPLC (a) and pHEA-SEC (b) at 4 g and 20 g
was complete in 8 min while the rpHPLC run
approximate total volume of the column as disc
20 g injection yielded mass data with suffic
separation, both samples yielded good ionization
in MS signal over the 4 g. For comparison of the
compared for each method (c). The area of the TI
higher in intensity than that for the 20 g rpHPLC aby the decrease of formic acid concentration, resulting
in less absorbance. This negative peak marks the “total
volume” of the column at about 750 L and has been
supported by the injection of pure water (data not
shown).
Figure 2 shows a comparison of the raw spectra
corresponding to the 4 g pHEA-SEC and 20 g
rpHPLC analyses. The excellent peak shape and signal
intensity obtained by pHEA-SEC is visible in both the
full range spectra and the detail view of the 48 charge
state. In contrast, the rpHPLC introduced sample
showed a much lower signal to noise ratio that can
be clearly seen in both views of the raw spectra. The
multiple peaks present at each charge state are due to
heterogeneity of the N-linked carbohydrates found on
the molecule. This is clearly shown by the deconvoluted
spectrum shown for each sample in Figure 3. For each
spectrum, the major species are practically identical,
with 162 Da spacing between different masses due to
heterogeneous terminal galactosylation on the N-linked
carbohydrates of the antibody. The correspondence of
the mass data with expected values was 24 ppm for
major species in each dataset. Although the pattern of
major species in the deconvolution was similar for each
ned for a non-reduced antibody separated by
ple load levels. Note that the pHEA-SECmethod
e 30 min long. The arrow in (b) indicates the
in the text. For the rpHPLC analysis, only the
intensity for comparison. For the pHEA-SEC
h the 20 g injection yielding only a 1.7 increase
l ion current (TIC) traces, typical injections were
ce for the 4 g pHEA-SEC run was over 45-foldobtai
sam
s wer
ussed
ient
, wit
tota
C tranalysis.
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cleaner baseline, with fewer minor peaks observed.
Satellite peaks present in deconvoluted data of antibod-
ies have been previously described [15] and are a
common (and not fully understood) hallmark of this
type of analysis. Reduction of these artifacts in the
deconvoluted data obtained by pHEA-SEC simplifies
the interpretation of the data and is an advantage of the
method over rpHPLC based approaches.
To show the flexibility of the pHEA-SEC method to
analyze antibodies without additional method devel-
Figure 2. Comparison of the summed full-sca
rpHPLC (c) analyses. Panels at right show a
pHEA-SEC (b) and rpHPLC (d) spectra. The pH
and less noisy data relative to rpHPLC.
Figure 3. Comparison of the deconvoluted data obtained from
pHEA-SEC (a) and rpHPLC (b). Signals have been normalized to
the most intense species in each trace. The mass data has been
reported to the nearest Dalton to be consistent with the 1.0 Da
resolution used by MaxEnt1 to deconvolute these data. The mass
accuracy for the major species in each sample was 24 ppm.opment, we tested several different antibodies under
non-reducing conditions. The observed mass values
and mass errors for these samples are reported in
Table 1. Antibody ‘A’ listed in this table corresponds
to the data presented in Figures 1–3. These values, all
below 25 ppm in mass accuracy, show that this
method is broadly applicable to the intact mass
analysis of antibodies.
Another advantage of pHEA-SEC is the ability to
efficiently desalt proteins of vastly different sizes. To
demonstrate this aspect of the separation, we applied
pHEA-SEC to resolution of reduced light and heavy
chains corresponding to Antibody ‘A’. Reduced anti-
bodies provide a good test of the method since reduc-
tion typically uses high concentrations of denaturants,
reducing agent, and other salts, in contrast to the
analysis of intact antibodies. The UV trace shown in
Figure 4 shows the separation of antibody light and
heavy chains in the presence of 6M GnHCl and 20 mM
spectra obtained for both pHEA-SEC (a) and
l view of the 3074 m/z charge-state from the
EC method generates significantly higher signal
Table 1. Observed mass values for non-reduced antibodies by
pHEA-SEC MS*
Antibody
Major observed
mass (Da)
Agreement with
expected (ppm)
Antibody A 147,519 Da 24
Antibody B 149,384 Da 5.4
Antibody C 148,247 Da 22
Antibody D 147,098 Da 6.1
Antibody F 147,190 Da 7.1
*Intact mass data obtained for five antibodies by pHEA-SEC MS.le raw
detai
EA-SSpectra were summed and mass values determined as discussed in the
Experimental section.
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observed for intact antibody (see Figure 1b), a peak
eluting in the same location, but with a somewhat less
ideal peak shape, was observed. Additionally, a second,
more intense peak corresponding to the salts and DTT
present in the sample was observed to elute just after 6
min. As for intact mass analysis, a negative deflection of
the baseline due to a local decrease in formic acid
concentration was observed at 7.5 min, marking the
total volume of the column. A comparison of the TIC
trace with that from the previously discussed non-
reduced data showed an increase in signal (with equiv-
alent sample loads) of about 6-fold for the reduced
sample. This is consistent with the relatively stronger
ionization of reduced light and heavy chains compared
with intact antibody. Analysis of the spectra corre-
sponding to the reduced protein peak indicated that
heavy chain was slightly biased to the earlier eluting
region of the peak but separation between the two was
insufficient to allow separate deconvolution. For further
analysis, the entire protein elution area was integrated
to obtain a mixed spectrum with both light and heavy
chain components as shown in the lower panel of
Figure 4.
Comparison of the ionization profiles for the two
components of the sample showed roughly 2-fold
Figure 4. A214 nm UV data (a) and raw ESI-M
comparison of the TIC traces for the reduced me
Figure 1. (d) Shows a magnified region of the sp
solid bar superimposed on the image.higher signal intensity for light chain, but close inspec-tion of the data showed good ionization for heavy chain
and allowed multiple ions present at each charge-state
to be distinguished. When the greater mass and heter-
ogeneity of heavy chain (due to glycosylation) is taken
into account, the lower signal relative to light chain is
explained. Deconvoluted traces corresponding to re-
duced antibody ‘A’ are shown in Figure 5. Comparison
of the observed and expected masses for each subunit
showed mass accuracy for each was below 25 ppm. For
heavy chain, heterogeneity due to glycosylation was
resolved, primarily due to terminal galactosylation dif-
ferences as discussed for intact mass data above.
To demonstrate the potential for the method as a
screening tool, we tested a reduced antibody sample
derived from clarified cell-culture supernatant. Deconvo-
luted data corresponding to the heavy chain subunit for
the control and test sample is shown in lower panels of
Figure 5. The high-quality of the data allowed differences
in the glycosylation profile to be observed. This type of
analysis shows the ability of this method to be used for
samples from a challenging sample matrix where protein
concentrations may be low in comparison to levels of
interfering components that are often poorly removed by
rpHPLC. This example illustrates the potential of this
method for analysis of in-process samples.
Finally, we analyzed a sample of antibody (antibody
spectra for reduced antibody ‘A.’ (b) Shows a
and the intact mass data (4 g load level) from
shown in (c) from the region indicated by theS (c)
thod
ectra‘D’ in Table 1) enriched for dimeric species as deter-
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ple, but not mass analysis data, have been previously
published [16]). Analysis of aggregated antibody sam-
ples by mass spectrometry is a challenge, made even
more so by the difficulty of obtaining efficient desalting
Figure 5. Comparison of the deconvoluted da
sponding to antibody ‘A’ is shown for light cha
spectrum has been normalized to 100% for each
21.2 ppm and 0.2 ppm for heavy chain (major sp
and heavy chains from several separately prep
typical mass accuracy ranges of 5 to 25 ppm for
the heavy chain of an antibody analyzed directly
control (c), with mass accuracy of 9 ppm for the
minor species present in the deconvolution of re
the text for intact antibodies) but can usually be
methods.before sample introduction to the mass spectrometer.Separation of aggregates by rpHPLC usually results in
extremely poor peak shapes, inefficient desalting, and
difficulty in fully eluting the protein from the hydro-
phobic matrix. To reduce sample heterogeneity and
simplify interpretation of the mass data, samples were
r two reduced antibodies. Reduced data corre-
(a) and heavy chain in (b). Each deconvoluted
layed region. Mass accuracy for light chain was
). Comparison of mass accuracy values for light
samples (analyzed on different days) showed
chain. A comparison of deconvoluted data for
a cell-culture supernatant (d) is compared with
r species shown in each. It should be noted that
d samples are not typically artifacts (as noted in
ted to components in the sample by orthogonalta fo
in in
disp
ecies
ared
each
from
majo
duce
relatreated before analysis with PNGaseF to remove
508 BRADY ET AL. J Am Soc Mass Spectrom 2008, 19, 502–509N-linked carbohydrates. Separation of the dimeric sam-
ple by pHEA-SEC resulted in a similar UV chromato-
gram to that shown for intact antibody in Figure 1.
Figure 6 shows a comparison of the raw and deconvo-
luted data for control and dimeric samples analyzed
under non-reducing conditions.
Comparison of the raw spectra for each sample
showed the presence of a single charge-state envelope
for the control (monomeric) sample and two overlap-
ping envelopes for the dimeric sample. An overlay of
the two multiply charged spectra showed that every
other species was unique to the dimeric sample, sug-
gesting the presence of both monomer and dimer. To
compare the data, each sample was deconvoluted to
include both monomeric and dimeric mass output
ranges. Due to the larger peak width of the data for the
dimer sample, a peak width value of 2.5 Da was used
Figure 6. Raw and deconvoluted mass results
spectra for the monomeric control (a) show
corresponding to dimer (b) show two overlapp
spectra (using a 2.5 Da peak width) across the
showed only monomeric mass for the control (c)
for the dimer sample (e). (d) Shows an example
peak width with an expanded view of the mono
analysis of the control was 23 ppm; mass accura
was 137 ppm. (f) Shows an overlay of the spec
arrows indicate charge states that are specific to thefor the deconvolution program; this setting was also
used for the monomeric sample to provide comparative
data. Narrower peak widths could not be used for the
dimer sample without anomalous deconvolution re-
sults (data not shown). Use of a narrower peak width
(see Figure 6) for the control sample resulted in a more
accurate monomer mass nearly 20 Da lower in mass and
closer to the expected value. The use of the wider peak
width for both samples was done to demonstrate that
no appreciable difference in monomer mass value was
determined by deconvolution. Comparison of the de-
convoluted data for each sample showed the presence
of a 144 kDa monomeric species of nearly identical
mass. For the dimeric sample only, an additional spe-
cies was observed at 288 kDa consistent with a covalent
dimer. This observation was supported by additional
data beyond the scope of this report that showed the
n antibody dimer compared with control. Raw
gle multiply charged spectrum, while those
charge-state series. Deconvolution of both raw
e of monomer and dimer output mass values
he presence of both monomer and dimer masses
e control sample deconvoluted with a 0.75 Da
ass. Mass accuracy for the 0.75 Da peak width
r the control analyzed with a 2.5 Da peak width
r the monomer control and the dimer sample;for a
a sin
ing
rang
but t
of th
mer m
cy fo
tra fodimeric species only.
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species within the sample.
The successful analysis and deconvolution of a
dimeric antibody of nearly 300 kDa in mass shows the
flexibility of this simple but powerful sample introduc-
tion procedure. Combined with the results from re-
duced antibody analysis, this example shows that this
method can be applied to proteins over 10-fold size
difference (23.4 kDa light chain to 288 kDa antibody
dimer) without additional method development.
Conclusions
We report a method optimized on a widely available
column that allows easy analysis of antibodies under
either non-reduced or reduced conditions by mass
spectrometry. This fast method has an analysis time
below 10 min per sample and shows greater ionization
sensitivity when coupled with ESI-MS than similar
analyses achieved by rpHPLC. Additionally, the ability
to operate the column at ambient temperature is advan-
tageous, and minimizes the potential for analysis arti-
facts due to chromatographic column heating. Experi-
ments performed with reduced, in-process, intact, and
dimeric antibody samples show the flexibility of the
method for different sample types. In addition to the
data presented here, we have successfully used this
method to characterize fractions from analytical scale
cation exchange and hydrophobic interaction chroma-
tography. This method should prove powerful wher-
ever mass data is required to characterize samples
purified by an orthogonal method, especially where
those methods result in samples in high concentrations
of salts or other buffer components.
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